More Cheer For Biocon-Mylan As Brazil Clears Biosimilar Trastuzumab

 
• By Anju Ghangurde
  
Rio
MYLAN-BIOCON HAVE RECEIVED APPROVAL FOR THEIR HERCEPTIN BIOSIMILAR IN BRAZIL
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Business

More from Generics Bulletin